Prepubertal gynecomastia during growth hormone therapy.

Malozowski, S; Stadel, B V

Malozowski, S; Stadel, B V.

Afiliación

Malozowski S; Division of Metabolism and Endocrine Drug Products, U.S. Food and Drug Administration, Rockville, Maryland 20857, USA.

J Pediatr ; 126(4): 659-61, 1995 Apr.

Article en En | MEDLINE | ID: mdl-7699552

RESUMEN

We report 22 cases of prepubertal gynecomastia diagnosed during growth hormone (GH) treatment. The age and dose range were 2 to 12 years and 0.18 [corrected] to 0.3 mg/kg per week, respectively. In most of the patients, gynecomastia appeared between 0.5 and 7 months after GH was started. Three boys were using drugs other than GH. This condition appears to be self-limited and benign.

Asunto(s)

Hormona del Crecimiento/efectos adversos; Ginecomastia/inducido químicamente; Niño; Preescolar; Hormona del Crecimiento/uso terapéutico; Humanos; Masculino

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hormona del Crecimiento / Ginecomastia Límite: Child / Child, preschool / Humans / Male Idioma: En Revista: J Pediatr Año: 1995 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links